Circular Genomics Secures $15M to Advance Alzheimer’s Early Detection
A New Era in Alzheimer’s Detection Circular Genomics, a leader in circular RNA-based precision medicine, has closed a $15 million Series A financing round. This funding will accelerate the development of its innovative platform for the early detection of Alzheimer’s disease. The financing was led by Mountain Group Partners. Other participants included Poplar Grove Investors, HIP […]